Indian J Pharm Close
 

Figure 2: Patient X in the scalp cooling group with Grade 1 alopecia at the last cycle of taxotere and cyclophosphamide (75 mg/m2 docetaxel and 600 mg/m2 cyclophosphamide)

Figure 2: Patient X in the scalp cooling group with Grade 1 alopecia at the last cycle of taxotere and cyclophosphamide (75 mg/m<sup>2</sup> docetaxel and 600 mg/m<sup>2</sup> cyclophosphamide)